Further studies in xenobiotic metabolism and Parkinson's disease.
Ramsden
D B
DB
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, U.K.
Parsons
R B
RB
Ho
S L
SL
Xie
T
T
Waring
R H
RH
Williams
A C
AC
D002394:Catechol O-Methyltransferase / Q000378:metabolism; D050558:Cysteine Dioxygenase; D049308:Dioxygenases; D006801:Humans; D008780:Methyltransferases / Q000378:metabolism; D050903:Nicotinamide N-Methyltransferase; D010105:Oxygenases / Q000378:metabolism; D010300:Parkinson Disease / Q000209:etiology / Q000235:genetics* / Q000378:metabolism*; D015262:Xenobiotics / Q000009:adverse effects / Q000493:pharmacokinetics*
D015262:Xenobiotics; D010105:Oxygenases; D049308:Dioxygenases; D050558:Cysteine Dioxygenase; D008780:Methyltransferases; C494406:NNMT protein, human; D050903:Nicotinamide N-Methyltransferase; D002394:Catechol O-Methyltransferase